Revvity Inc. $RVTY Shares Purchased by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. increased its holdings in shares of Revvity Inc. (NYSE:RVTY) by 32.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 52,145 shares of the company’s stock after buying an additional 12,697 shares during the period. Envestnet Asset Management Inc.’s holdings in Revvity were worth $4,571,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in RVTY. EdgePoint Investment Group Inc. grew its stake in shares of Revvity by 26.7% in the second quarter. EdgePoint Investment Group Inc. now owns 6,789,660 shares of the company’s stock worth $656,696,000 after acquiring an additional 1,428,813 shares in the last quarter. Invesco Ltd. boosted its holdings in Revvity by 25.8% in the second quarter. Invesco Ltd. now owns 2,207,202 shares of the company’s stock valued at $213,481,000 after purchasing an additional 452,343 shares during the period. Primecap Management Co. CA grew its stake in Revvity by 18.7% during the 2nd quarter. Primecap Management Co. CA now owns 1,359,641 shares of the company’s stock worth $131,504,000 after purchasing an additional 214,056 shares in the last quarter. Norges Bank purchased a new stake in Revvity during the 2nd quarter worth about $124,574,000. Finally, Massachusetts Financial Services Co. MA raised its position in Revvity by 26.6% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 1,160,225 shares of the company’s stock valued at $112,217,000 after purchasing an additional 243,689 shares in the last quarter. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Stock Down 3.3%

Shares of NYSE:RVTY opened at $97.01 on Tuesday. The firm has a 50 day simple moving average of $103.17 and a 200-day simple moving average of $96.22. Revvity Inc. has a twelve month low of $81.36 and a twelve month high of $120.39. The company has a current ratio of 1.68, a quick ratio of 1.40 and a debt-to-equity ratio of 0.36. The company has a market capitalization of $11.00 billion, a PE ratio of 46.64, a P/E/G ratio of 2.13 and a beta of 1.06.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Monday, February 2nd. The company reported $1.70 EPS for the quarter, topping the consensus estimate of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The firm had revenue of $772.06 million for the quarter, compared to analyst estimates of $759.81 million. During the same period last year, the business earned $1.42 EPS. Revvity’s revenue for the quarter was up 5.9% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. On average, equities analysts predict that Revvity Inc. will post 4.94 EPS for the current fiscal year.

Revvity announced that its Board of Directors has authorized a share buyback plan on Monday, October 27th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to buy up to 8.7% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s management believes its shares are undervalued.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 8th. Stockholders of record on Friday, April 17th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Friday, April 17th. Revvity’s payout ratio is presently 13.46%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on RVTY shares. TD Cowen reissued a “hold” rating on shares of Revvity in a research report on Tuesday, February 3rd. JPMorgan Chase & Co. boosted their price target on shares of Revvity from $100.00 to $105.00 and gave the stock a “neutral” rating in a report on Tuesday, February 3rd. Robert W. Baird set a $129.00 price objective on shares of Revvity in a research report on Tuesday, February 3rd. Evercore lifted their price objective on shares of Revvity from $112.00 to $118.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 3rd. Finally, Jefferies Financial Group boosted their target price on shares of Revvity from $100.00 to $105.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. Five equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $113.67.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.